Wyszukiwarka
Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolemia: A Propensity Score Analysis
Abstrakt
Background: The monogenic defect in familial hypercholesterolemia (FH) is detected in ∼40% of cases. The majority of mutation-negative patients have a polygenic cause of high LDL-cholesterol (LDL-C). We sought to investigate whether the underlying monogenic or polygenic defect is associated with the response to rosuvastatin. Methods: FH Individuals were tested for mutations in LDLR and APOB genes. A previously established LDL-C-specific polygenic risk score (PRS) was used to examine the possibility of polygenic hypercholesterolemia in mutation-negative patients. All of the patients received rosuvastatin and they were followed for 8 ± 2 months. A propensity score analysis was performed to evaluate the variables associated with the response to treatment. Results: Monogenic subjects had higher mean (±SD) baseline LDL-C when compared to polygenic (7.6 ± 1.5 mmol/L vs. 6.2 ± 1.2 mmol/L; p < 0.001). Adjusted model showed a lower percentage of change in LDL-C after rosuvastatin treatment in monogenic patients vs. polygenic subjects (45.9% vs. 55.4%, p < 0.001). The probability of achieving LDL-C targets in monogenic FH was lower than in polygenic subjects (0.075 vs. 0.245, p = 0.004). Polygenic patients were more likely to achieve LDL-C goals, as compared to those monogenic (OR 3.28; 95% CI: 1.23-8.72). Conclusion: Our findings indicate an essentially higher responsiveness to rosuvastatin in FH patients with a polygenic cause, as compared to those carrying monogenic mutations.
Cytowania
-
9
CrossRef
-
0
Web of Science
-
1 1
Scopus
Autorzy (12)
-
Agnieszka Mickiewicz
-
Marta Futema
-
Agnieszka Ćwiklinska
-
Agnieszka Kuchta
-
Maciej Jankowski
-
Magdalena Chmara
-
Bartosz Wasąg
-
Marcin Fijałkowski
-
Miłosz Jaguszewski
-
Steve E. Humphries
-
Marcin Gruchała prof
Cytuj jako
Pełna treść
- Wersja publikacji
- Accepted albo Published Version
- DOI:
- Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.3390/life10050073
- Licencja
-
otwiera się w nowej karcie
Słowa kluczowe
Informacje szczegółowe
- Kategoria:
- Publikacja w czasopiśmie
- Typ:
- artykuły w czasopismach
- Opublikowano w:
-
Life
nr 10,
ISSN: 0024-3019 - Język:
- angielski
- Rok wydania:
- 2020
- Opis bibliograficzny:
- Mickiewicz A., Futema M., Ćwiklinska A., Kuchta A., Jankowski M., Kaszubowski M., Chmara M., Wasąg B., Fijałkowski M., Jaguszewski M., Humphries S. E., Gruchała M.: Higher Responsiveness to Rosuvastatin in Polygenic versus Monogenic Hypercholesterolemia: A Propensity Score Analysis// Life -Vol. 10,iss. 5 (2020), s.73-
- DOI:
- Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) 10.3390/life10050073
- Weryfikacja:
- Politechnika Gdańska
wyświetlono 103 razy
Publikacje, które mogą cię zainteresować
CARDIOVASCULAR RISK FACTORS AMONG POLISH EMPLOYEES OF UNIFORMED SERVICES
- B. G. Trzeciak,
- W. Kowalczyk,
- S. Grymek
- + 2 autorów
Gender-Related Differences in Trimethylamine and Oxidative Blood Biomarkers in Cardiovascular Disease Patients
- L. Bordoni,
- D. Fedeli,
- M. Piangerelli
- + 8 autorów